Details for New Drug Application (NDA): 089595
✉ Email this page to a colleague
NDA 089595 describes TRIANEX, which is a drug marketed by Cmp Pharma Inc and is included in one NDA. It is available from one supplier. Additional details are available on the TRIANEX profile page.
The generic ingredient in TRIANEX is triamcinolone acetonide. There is one drug master file entry for this compound. Eighty suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
The generic ingredient in TRIANEX is triamcinolone acetonide. There is one drug master file entry for this compound. Eighty suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 089595
| Tradename: | TRIANEX |
| Applicant: | Cmp Pharma Inc |
| Ingredient: | triamcinolone acetonide |
| Patents: | 0 |
Pharmacology for NDA: 089595
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 089595
Suppliers and Packaging for NDA: 089595
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TRIANEX | triamcinolone acetonide | OINTMENT;TOPICAL | 089595 | ANDA | CMP Pharma, Inc. | 46287-010 | 46287-010-11 | 110 g in 1 JAR (46287-010-11) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 0.05% | ||||
| Approval Date: | Mar 23, 1995 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
